ENDOTHELIAL CELL PROLIFERATION IN PPH
ENDOTHELIAL CELL PROLIFERATION IN PPH
批准号:
6184752
负责人:
NORBERT F VOELKEL
金额:
$23.13万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2001-07-31
关键词:
angiogenesis aromatic hydrocarbon receptor cell growth regulation cell proliferation cellular pathology electrophoresis gene expression genetic library genetic transcription human tissue protein sequence pulmonary artery pulmonary hypertension receptor expression tissue /cell culture vascular endothelial growth factors vascular endothelium vascular resistance vascular smooth muscle
中文摘要
描述:原发性肺动脉高压(PPH)是一种毁灭性的
以家族性和零星形式发生的疾病。这个
调查人员发现,PPH与
丛源性继发性肺动脉高压(2PH)
PPH中的增殖性内皮细胞多为单克隆性
在第二次PH中,它们是严格的多克隆。调查人员假设
PPH中增殖的单克隆性扩张性内皮细胞
具有内皮干细胞的特性。此外,调查人员
推测a)PPH的发病机制可通过以下方式理解
调查被误导的血管生成/血管生成的概念;b)
一种芳烃受体(AHR)-芳烃受体
核转运蛋白(ARNT)和缺氧诱导因子1b(HIF-1b)
相互作用可能参与了肺动脉内皮细胞的生长
控制力。PI的方法将是通过显微解剖从
PPH患者肺、“高血压”血管内皮细胞和血管平滑肌
细胞来生成细胞特异性的cDNA文库,以应用这项技术
基因表达序列分析(SAGE)和二维蛋白质
电泳法以鉴定基因和蛋白质的表达
单克隆性和多克隆性“高血压”型肺动脉
细胞。AHR/Arnt转录系统的功能重要性
对于肺动脉高压,内皮细胞的生长将在
慢性剪应力暴露的细胞培养系统使用激活剂和
AHR的抑制剂和Arnt E盒的转录因子诱饵
核心序列。
英文摘要
DESCRIPTION: Primary Pulmonary Hypertension (PPH) is a devastating
disease which occurs in a familial and in a sporadic form. The
investigators have found that PPH is categorically different from
plexogenic secondary pulmonary hypertension (2nd PH), in that the
proliferative endothelial cells in PPH are mostly monoclonal, whereas
they are strictly polyclonal in 2nd PH. The investigators postulate
that the proliferating monoclonally expanding endothelial cells in PPH
have properties of endothelial stem cells. Further, the investigators
speculate that a) The pathogenesis of PPH can be understood by
investigating the concept of misguided vasculogenesis/angiogenesis; b)
That an aryl hydrocarbon receptor (AHR) -aryl hydrocarbon receptor
nuclear transporter (ARNT) and hypoxia-inducible factor 1b (HIF-1b)
interaction may be involved in pulmonary artery endothelial cell growth
control. The PI's approach will be to obtain, via microdissection from
PPH patient lungs, "hypertensive" endothelial and vascular smooth muscle
cells to generate cell-specific cDNA libraries, to apply the technique
of serial analysis of gene expression (SAGE) and two-dimensional protein
electrophoresis in order to characterize the gene and protein expression
pattern of monoclonal and polyclonal "hypertensive" pulmonary artery
cells. The functional importance of the AHR/ARNT transcription system
for pulmonary hypertensive endothelial cell growth will be examined in
chronic shear stress exposed cell culture system using activators and
inhibitors of AHR and a transcription factor decoy of the ARNT E box
core sequence.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.amjcard.2015.06.015
发表时间:
2015-09-15
期刊:
The American journal of cardiology
影响因子:
--
作者:
[Grayburn PA, She L, Roberts BJ, Golba KS, Mokrzycki K, Drozdz J, Cherniavsky A, Przybylski R, Wrobel K, Asch FM, Holly TA, Haddad H, Yii M, Maurer G, Kron I, Schaff H, Velazquez EJ, Oh JK]
通讯作者:
Oh JK
DOI:
10.1186/rr59
发表时间:
2001
期刊:
Respiratory research
影响因子:
5.8
作者:
[Geraci MW, Gao B, Hoshikawa Y, Yeager ME, Tuder RM, Voelkel NF]
通讯作者:
Voelkel NF
Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension.
前列环素治疗肺动脉高压后移植肺的形态变化。
DOI:
--
发表时间:
2006
期刊:
European journal of medical research.
影响因子:
--
作者:
[Achcar,RosaneOD, Yung,GordonL, Saffer,Helene, Cool,CarlyneD, Voelkel,NorbertF, Yi,EunheeS]
通讯作者:
Yi,EunheeS
Bone marrow-derived precursor cells and angioproliferative PH
-
批准号:8176298
-
项目类别:
-
资助金额:$22.43万
-
财政年份:2011
-
负责人:NORBERT F VOELKEL
-
依托单位:
Bone marrow-derived precursor cells and angioproliferative PH
-
批准号:8302191
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2011
-
负责人:NORBERT F VOELKEL
-
依托单位:
Misguided angiogenesis, plexiform pulmonary hypertension
-
批准号:6642927
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6780965
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6666770
-
项目类别:
-
资助金额:$31.61万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6570697
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Exhaled Air Biomarkers in COPD
-
批准号:6923700
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2002
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6642859
-
项目类别:
-
资助金额:$110.26万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6367527
-
项目类别:
-
资助金额:$123.59万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6756738
-
项目类别:
-
资助金额:$13.01万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6932438
-
项目类别:
-
资助金额:$116.32万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6779908
-
项目类别:
-
资助金额:$113.7万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
Pathobiology of Severe Pulmonary Hypertension
-
批准号:6527690
-
项目类别:
-
资助金额:$106.7万
-
财政年份:2001
-
负责人:NORBERT F VOELKEL
-
依托单位:
ENDOTHELIAL CELL PROLIFERATION IN PPH
-
批准号:2688228
-
项目类别:
-
资助金额:$32.45万
-
财政年份:1998
-
负责人:NORBERT F VOELKEL
-
依托单位:
ENDOTHELIAL CELL PROLIFERATION IN PPH
-
批准号:6044043
-
项目类别:
-
资助金额:$27.27万
-
财政年份:1998
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN IN SYNTHESIS PULMONARY HYPERTENSION
-
批准号:2220915
-
项目类别:
-
资助金额:$21.84万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN IN SYNTHESIS PULMONARY HYPERTENSION
-
批准号:3361720
-
项目类别:
-
资助金额:$20.5万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN SYNTHESIS IN PULMONARY HYPERTENSION
-
批准号:6151269
-
项目类别:
-
资助金额:$26.52万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN SYNTHESIS IN PULMONARY HYPERTENSION
-
批准号:2872896
-
项目类别:
-
资助金额:$22.31万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
PROSTACYCLIN SYNTHESIS IN PULMONARY HYPERTENSION
-
批准号:2486027
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1992
-
负责人:NORBERT F VOELKEL
-
依托单位:
海外基金